Profile details
About Jenny Park
Jenny is an associate in our global transactions group in New York. Her practice focuses on corporate and financial transactions, particularly mergers and acquisitions.
Recent work
- Novartis on its pending €2.7 billion acquisition of MorphoSys AG.
- AstraZeneca on its $1.2 billion acquisition of Gracell Biotechnologies Inc.
- Li-Cycle in connection with its adoption of a limited duration shareholder rights plan.
- Blackstone portfolio company, Schenck Process Group, on the sale of its food and performance materials business to Hillenbrand, Inc.
- Molekule Group on its all-stock merger with Aura Smart Air.
- London Stock Exchange Group on its acquisition of AcadiaSoft.
- CarLotz on its sale to Shift Technologies.
- Zymergen on its pending $300 million sale to Ginkgo Bioworks.